Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: A cohort study
rhTPO was not associated with any significant safety issues and was well tolerated by pediatric and adolescent patients with hematologic diseases who underwent allo-HSCT. Our results suggested that rhTPO may benefit allo-HSCT in children and adolescents by improving PLT recovery.
Authors
- Yanfang Xu
- Wei Chen (ORCID: https://orcid.org/0000-0001-6048-1860)
- Yao Tong (ORCID: https://orcid.org/0009-0003-5605-5078)
- Fen Chen (ORCID: https://orcid.org/0000-0002-2791-1918)
- Ru-Min Wang
- Tao Lang (ORCID: https://orcid.org/0000-0003-2954-2113)
- Xue-Guo Li
Institutions
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Publication Details
- Journal
- World Journal of Stem Cells
- Published
- 2025-07-24
- DOI
- https://doi.org/10.4252/wjsc.v17.i7.106579
- Citations
- 2
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 3.54